| 摘要 |
The present invention relates to compounds of the formula (I), wherein R<SUP>1 </SUP>and R<SUP>2 </SUP>are as defined in the description; to pharmaceutical formulations comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and/or body weight gain.
|
